Skip to content

Using purity based messages to increase intention to receive the HPV vaccine

HPV, genital warts, and purity: A 2x2 study of college-aged individuals’ perceptions of HPV and intention to receive the HPV vaccine

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ISRCTN
Registry ID
ISRCTN51541314
Enrollment
2556
Registered
2020-08-12
Start date
2020-08-12
Completion date
Unknown
Last updated
2020-09-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Sexually transmitted disease awareness Infections and Infestations

Interventions

Participants will be randomized using a Qualtrics algorithm. The algorithm randomly presents either the control statement, the control statement + control image, experimental statement, or experimenta

Sponsors

Yale School of Medicine
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Between 18 and 23 years of age (inclusive) 2. Resident of the United States 3. Has received no more than 2 doses of the HPV vaccine

Exclusion criteria

Exclusion criteria: 1. Has completed the HPV vaccine series (3 or more doses) 2. Has already completed the survey

Design outcomes

Primary

MeasureTime frame
Intent to receive the HPV vaccine, measured once during a post-intervention survey administered immediately after the visual message has been reviewed by the participant. (The method of measurement is a single question asking if the participants intend to initiate [if they have received 0 HPV vaccine doses) or continue (if they have received 1-2 HPV vaccine doses] the HPV vaccine series)

Secondary

MeasureTime frame
1. Vaccine confidence as measured by the Vaccine Confidence Scale at post intervention 2. Purity/liberty measured using the moral foundations questionnaire before the intervention

Countries

United States of America

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 4, 2026